The filing is a standard advance notice for a planned insider sale tied to tax obligations on vested equity. No material impact expected; monitor for any acceleration of insider selling patterns or changes in executive holdings.
TAK drugs
TAK drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 2 $20.87entry
- T+1 · 14d ago −0.57%α −0.87% · $20.75
- T+5 · 8d ago +1.05%α +0.98% · $21.09
- T+10 · todayOpen
- T+20 · in 14d Pending
- T+60 · in 2mo Pending
Price Chart
How similar events traded
Executive Summary
Giles Richard Platford, President of Takeda's International Business Unit, filed a Form 144 notice of intent to sell 55,617 American Depositary Shares (ADSs) with an approximate market value of $1.12 million. The shares were acquired via vested restricted stock unit awards on July 30, 2024, and the sale is scheduled for or after November 1, 2026. The filing is a routine insider sale for tax-related purposes, representing a small fraction of the company's $63.7 billion market cap.
Key Facts
- Insider Giles Richard Platford (President, International Business Unit) filed Form 144 to sell 55,617 ADSs.
- Estimated aggregate market value of the proposed sale is approximately $1,121,794.89.
- Shares were acquired via vested restricted stock unit awards on July 30, 2024, as compensation.
- Proposed sale date is November 1, 2026.
- A prior sale of 31,083 ADSs on August 10, 2026, was conducted to satisfy tax obligations related to share vesting.
- The sale represents about 0.0018% of Takeda's $63.7B market cap.
Financial Impact
Proposed sale of 55,617 ADSs valued at ~$1.12 million, a negligible 0.0018% of market cap.
Risk Factors
- Form 144 signals intent to sell, but the actual sale may not occur.
- No additional context on company performance or upcoming catalysts provided in the filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001493152-26-049487 |
| Document: 0001493152-26-049487-index.html | 0001493152-26-049487 |
| Document: 0001493152-26-049487.txt | 0001493152-26-049487 |
Track record
18 reports on TAK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Viewing Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 29, 202618d ago 6-K Neutral 4/10 No price data
- Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
- Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
- Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers